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Structural Snapshots of Human HDAC8 Provide
Insights into the Class I Histone Deacetylases
types with HDAC inhibitors (HDIs) does not cause a
global increase in transcription. Instead, only a small
percentage of the genome is affected (Glaser et al.,
John R. Somoza,1,3,* Robert J. Skene,2
Bradley A. Katz,1 Clifford Mol,2 Joseph D. Ho,1
Andy J. Jennings,2 Christine Luong,1
Andrew Arvai,2 Joseph J. Buggy,1 Ellen Chi,2 2003; Van Lint et al., 1996). Treatment with HDIs causes
tumor cells to cease growth and to either differentiateJie Tang,1 Bi-Ching Sang,2 Erik Verner,1
Robert Wynands,2 Ellen M. Leahy,1 or become apoptotic. These findings have led to interest
in the use of HDIs as antitumor agents, resulting in sev-Douglas R. Dougan,2 Gyorgy Snell,2 Marc Navre,2
Mark W. Knuth,2,4 Ronald V. Swanson,2,4 eral small molecules that are currently in clinical trials
for oncology indications (Johnstone, 2002). Moreover,Duncan E. McRee,2,4 and Leslie W. Tari2,3,*
1Celera a number of studies have shown potential application
of HDIs in the treatment of neurodegenerative disorders180 Kimball Way
South San Francisco, California 94080 (Hockly et al., 2003) and in the treatment of genetic
disorders such as -thalassemia (Witt et al., 2003).2 Syrrx, Inc.
10410 Science Center Drive Two related classes of eukaryotic zinc-containing
HDACs have been recognized based upon sequenceSan Diego, California 92121
similarity: class I (HDAC1, 2, 3, and 8) and class II
(HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al.,
2002). Another HDAC, HDAC11, lies at the boundarySummary
between the two classes. Both class I and II HDACs
possess well-conserved deacetylase core domains ofModulation of the acetylation state of histones plays
approximately 400 amino acids and apparently identicala pivotal role in the regulation of gene expression.
Zn2-dependent catalytic machinery (Figure 1). Class IHistone deacetylases (HDACs) catalyze the removal
HDACs are ubiquitously expressed and are primarilyof acetyl groups from lysines near the N termini of
located in the nucleus, while the class II enzymes canhistones. This reaction promotes the condensation of
shuttle between the nucleus and cytoplasm and demon-chromatin, leading to repression of transcription.
strate tissue-specific expression (Johnstone, 2002;HDAC deregulation has been linked to several types
Marks et al., 2001; Vigushin and Coombes, 2002).of cancer, suggesting a potential use for HDAC inhibi-
HDAC8 is a 377 residue class I enzyme that lies closetors in oncology. Here we describe the first crystal
to the phylogenetic boundary between the class I andstructures of a human HDAC: the structures of human
class II HDACs, and maps to the X chromosome (Hu etHDAC8 complexed with four structurally diverse hy-
al., 2000; Buggy et al., 2000; Van den Wyngaert et al.,droxamate inhibitors. This work sheds light on the
2000). The physiological role played by HDAC8 is gradu-catalytic mechanism of the HDACs, and on differences
ally being elucidated. Lee et al. (2004) have shown thatin substrate specificity across the HDAC family. The
HDAC8 is phosphorylated in vivo by cyclic AMP-depen-structure also suggests how phosphorylation of Ser39
dent protein kinase A (PKA), and that phosphorylationaffects HDAC8 activity.
decreases the activity of HDAC8 and leads to the
hyperacetylation of histones H3 and H4. This work indi-Introduction
cates that HDAC8, under the regulation of PKA, plays
an important role in determining the acetylation state ofAcetylation of the core histones of nucleosomes strongly
histones. Also, recent evidence suggests that HDAC8influences gene transcription (Khochbin et al., 2001;
may play a role in one of the most frequent types of acuteJohnstone, 2002). Two families of enzymes modulate
myeloid leukemia (AML). Inversion(16) is a chromosomalhistone acetylation: histone acetyl transferases (HATs)
translocation that frequently occurs in AML and resultsand histone deacetylases (HDACs), which catalyze the
in a protein product associated with abnormal transcrip-addition and removal, respectively, of acetyl moieties
tional repression. The inversion(16) protein product as-from the -amino groups of lysines near the amino ter-
sociates with HDAC8, and the repression that is medi-mini of histones. Histone deacetylation promotes the
ated by this complex is sensitive to HDAC inhibitorscondensation of chromatin which, in turn, promotes
(Durst et al., 2003).transcriptional repression (Struhl, 1998). The HDACs, in
We present the first three-dimensional structures ofparticular, the class I HDACs, play an important role in
a mammalian HDAC, including crystal structures ofgene silencing as they are recruited to key locations
HDAC8 complexed to trichostatin A (TSA), suberoylani-in nucleosomes through their interactions with tran-
lide hydroxamic acid (SAHA), 4-dimethylamino-N-(6-scription complexes such as Sin3 and NcoR (Ng and
hydroxycarbamoyethyl)benzamide-N-hydroxy-7-Bird, 2000). Interestingly, treatment of a variety of cell
(4-dimethylaminobenzoyl)aminoheptanamide (MS-344),
and 5-(4-methyl-benzoylamino)-biphenyl-3,4-dicar-
*Correspondence: john.somoza@celera.com (J.R.S.), ltari@syrrx. boxylic acid 3-dimethylamide 4-hydroxyamide (CRA-A)
com (L.W.T.)
(Figure 2A; Table 1). These inhibitors are active against3 These authors contributed equally to this work.
class I and class II HDACs, and have the ability to induce4 Present address: ActiveSight, 4045 Sorrento Valley Boulevard, San
Diego, California 92121. multiple effects within cells, including cell differentiation,
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Figure 1. Sequence Alignment of the Class I HDACs and HDLP
Residues that are identical across the enzymes are highlighted in blue, and the overall identities are 40%, 41%, 41%, and 31% between the
sequence of HDAC8 and the sequences of HDAC1, HDAC2, HDAC3, and HDLP, respectively. The key catalytic residues in HDAC8 are also
conserved in the class II HDACs. The sequences corresponding to the C-terminal domains of HDACs 1, 2, and 3 are not shown.
induction of cell cycle arrest, and suppression of tumor and encompass the residues that form the enzyme’s
growth (Jung et al., 1999; Almenara et al., 2002; Richon active site and catalytic machinery. A DALI search (Holm
et al., 1998; Yoshida et al., 1990a, 1990b). SAHA is cur- and Sander, 1994) of the Protein Data Bank revealed
rently in phase II clinical trials for the treatment of solid that HDAC8 has a core architecture similar to that found
tumors and hematologic malignancies. The HDAC8 in two enzymes: arginase, which catalyzes the conver-
structures shed light on the catalytic mechanism of the sion of arginine to ornithine (Kanyo et al., 1996), and an
class I and class II HDACs and provide new information HDAC-like protein (HDLP) from the hyperthermophilic
on substrate binding in the class I enzymes. These struc- bacterium Aquifex aeolicus (Finnin et al., 1999), an
tures also provide a framework for the identification of enzyme with no known function but which shares ap-
novel HDAC inhibitors. proximately 31% sequence identity with HDAC8. The
-carbons of the HDAC8 and arginase structures super-
impose with a root-mean-square deviation of 3.5 A˚ overResults and Discussion
two-thirds of the residues, primarily in the vicinity of the
central  sheet. The -carbons of the HDAC8 and HDLPOverall Structure of HDAC8
structures can be overlaid with root-mean-square devia-HDAC8 comprises a single / domain that includes an
tion of 2.2 A˚ over 90% of the residues. While the folds ofeight-stranded parallel  sheet sandwiched between 13
HDAC8 and HDLP are similar, the two protein structures helices (Figure 2B). While approximately half of the
differ dramatically in the outer portions of their activeamino acids are contained in canonical secondary struc-
sites, and in the conformations and topology of theirture elements, the other half of the residues in HDAC8
last 50 amino acid residues (Figure 2C).form loops that link the various elements of regular sec-
Comparisons of the structures of HDAC8 and HDLP,ondary structure. The long loops emanating from the
coupled with analysis of the sequence alignments of theC-terminal ends of the strands of the core  sheet form
a substantial portion of the volume of the entire enzyme class I HDACs and HDLP (Figure 1), reveal that HDAC8
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Figure 2. Overall Structure of HDAC8 and the Structures of the Four Hydroxamate Inhibitors
(A) Chemical structures of the four inhibitors used in this study. From left to right the inhibitors are TSA, SAHA, CRA-A, and MS-344.
(B) Ribbon diagram of the HDAC8:TSA complex showing the HDAC8 fold, as well as the inhibitors and the zinc ion. The TSA molecules are
shown in blue and pink, and the zinc ion is shown in orange.
(C) Stereo diagram showing superposition of the HDAC8:TSA structure (cyan) and the structure of apo HDLP (red) (Finnin et al., 1999). The
L1 loops of HDAC8 and HDLP are shown in green and yellow, respectively.
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Table 1. Data and Refinement Statistics
HDAC8:TSA HDAC8:MS-344 HDAC8:SAHA HDAC8:CRA-A
Data
Space group P43 P3121 P3121 P212121
Cell parameters (A˚) 81.0, 81,0, 114.2 80.6, 80.6, 105.5 80.8, 80.8, 105.6 82.6, 92.7, 98.8
Resolution range (A˚) 59.0–1.9 69.0–2.3 70.0–2.9 27.88–2.20
Total reflections 241,421 92,000 46,761 148,248
Unique reflections 54,547 16,130 8164 37,437
Completeness (last shell) (%) 99 (99) 94 (93) 95 (95) 91 (62)
Rsym(I) (last shell) (%) 5.8 (54.4) 5.1 (54.6) 7.6 (54.5) 9.2 (34.6)
I/(I) (last shell) 23.8 (2.5) 30.0 (2.2) 16.8 (4.0) 6.4 (1.6)
Model
Molecules in asymmetric unit 2 1 1 2
Number of water molecules 681 137 0 545
Other ligands 2 Zn2, 3 Ca2, 4 Na 1 Zn2, 2 Na 1 Zn2 2 Zn2, 2 Na
Resolution used for refinement (A˚) 59.0–1.9 69.0–2.3 70.0–2.9 7.0–2.2
Sigma cutoff (F/(F)) 0.0 0.0 0.0 1.1
R factor (Rfree, 5% of data) 17.2% (22.1%) 21.2% (27.4%) 24.9% (31.0%) 23.2% (30.6%)
Rms deviations from ideal geometry
Bonds (A˚) 0.010 0.009 0.010 0.018
Angles (	) 1.27 1.14 1.28 3.79
is structurally and, by implication, functionally unique in In each of the structures presented here, the tunnel is
filled by the aliphatic chain of the inhibitor. During theseveral key aspects. The main feature distinguishing
HDAC8 from the other class I enzymes is the absence deacetylation reaction, the tunnel is presumably occu-
pied by the four methylene groups of the acetylatedof a 50–111 amino acid C-terminal domain that extends
from the catalytic domain (which ends at residue 377 in lysine. The walls of the tunnel, formed by F152, F208,
H180, G151, M274, and Y306, are primarily hydrophobicHDAC8). In HDACs 1–3, the C-terminal domains are used
to recruit the enzymes to protein complexes that modu- (Figures 3A and 3B). These residues are conserved
across the class I HDACs, with the exception of M274,late their enzymatic activities and localization (Ayer,
1999). Additionally, the activities of class I HDACs are which is a leucine in the other family members (Figure 1).
The catalytic machinery lies at the end of the hy-regulated by posttranslational modifications to the
C-terminal extension, such as sumoylation (David et al., drophobic tunnel. The centerpiece of this region is a
zinc ion that is bound to carboxylate oxygens of D1782002) and phosphorylation (Tsai and Seto, 2002), which
may affect their catalytic activities via an allosteric and D267, and to the N
1 atom of H180 (Figure 3A and
3C). Two other coordination sites are occupied by themechanism and/or by altering their complex forming
capabilities. Given this difference between HDAC8 and carbonyl and hydroxyl oxygens of the inhibitors’ hydrox-
amate. It seems likely that when the natural substratethe other class I enzymes, it seems likely that HDAC8
either does not require recruitment to protein complexes binds, these coordination points would be occupied by
the carbonyl oxygen of the acetyl moiety and by a waterto function or that its recruitment utilizes entirely differ-
ent regions of the protein surface. A second feature molecule, respectively. The HDAC8 and HDLP struc-
tures, as well as mutagenesis (Hassig et al., 1998; Ka-distinguishing HDAC8 from HDLP and all other identified
class I HDACs is the size and composition of the N-terminal dosh and Struhl, 1998) and sequence conservation data
(Figure 1), suggest important structural/catalytic rolesL1 loop (residues 30–36, Figures 1 and 2C). In both
HDAC8 and HDLP, the L1 loop lines a large portion of for the bound zinc ion, for histidines 142 and 143, and
for Y306. D176 and D183 are also likely to be importantone face of the active site pocket and extends to the
protein surface (Figure 2C). However, the conformations for catalysis. The carboxylate moieties of these aspar-
tates form hydrogen bonds with the N
1 atom of eachof the L1 loops in HDAC8 and HDLP are dramatically
different, and the HDAC8 loop is two residues shorter histidine, similar to the Asp-His charge relay system
seen in serine proteases that is known to increase thethan its counterpart in HDLP (Figures 1 and 2C). The
result is that HDAC8 has a wider active site pocket with basicity of the imidazole N2 atom.
There is a second metal binding site buried in thea larger surface opening. Interestingly, the sequence
alignments shown in Figure 1 suggest that HDLP and interior of the protein in the vicinity of the active site,
approximately 7 A˚ from the zinc, which in the HDAC8HDACs 1–3 possess structurally homologous L1 loops,
and that HDAC8 is the structural outlier in the vicinity structures is occupied by a sodium ion (Figure 3A). The
metal is bound in an octahedral geometry by six oxygenof the L1 loop in the active site pocket. The functional
implications of this observation are discussed in a later ligands in the protein: the carboxylate of D176, the side
section. chain hydroxyl oxygen of S199, and the backbone car-
bonyl oxygens of residues 176, 178, 180, and 200. The
coordination distances between the sodium ion and co-The Structure of Active Site and Substrate
Binding Tunnel ordinating groups varies from 2.5 to 3.0 A˚. These dis-
tances and the octahedral coordination geometry areThe HDAC8 active site consists of a long, narrow tunnel
leading to a cavity that contains the catalytic machinery. consistent with what is commonly observed for sodium
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Figure 3. Interactions of HDAC8 with Inhibi-
tors and Substrate
(A) Stereo figure showing key residues in the
HDAC8 active site, two TSA molecules (blue
and pink), the zinc (orange), and the sodium
(purple). Potential hydrogen bonds are de-
picted as dashed lines.
(B) Fo  Fc simulated annealing omit maps
showing the electron density for the two mol-
ecules of TSA. The maps were contoured at
2.5 and are shown within 1.8 A˚ of the TSA
molecules.
(C) Schematic diagram showing the binding
of the hydroxamate inhibitors to HDAC8.
(D) Schematic diagram showing the pro-
posed model of how the acetylated lysine
would interact with the HDAC catalytic ma-
chinery.
ions in proteins (Harding, 2002). The role of the bound The sodium may modulate the basicity of the H142 N2
nitrogen through its interaction with D176. Alternatively,sodium atom is not clear, although a sequence compari-
son of the class I HDACs suggests that the binding site this ion may play a structural role in stabilizing the geom-
etry of the active site, as it coordinates and stabilizes afor this ion is conserved across this group of enzymes.
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Figure 4. The Surface of HDAC8 Is Malleable
and Changes to Accommodate Different In-
hibitors
(A) and (B) C traces show how the L1 loop
moves between the HDAC8:MS-344 (A) and
HDAC8:TSA (B) complexes. In (B), the L1 loop
of both structures is shown to facilitate the
comparison. In the HDAC8:TSA complex, the
K33 side chain is disordered and is not
shown. The -carbon of K33 moves by 6 A˚
toward the active site pocket in the MS-344
and SAHA (data not shown) complexes, so
that the methylene carbons of the K33 side
chain interact with the catalytic pocket lining
F152 residue, and the loop occludes the sec-
ond pocket that is present in the TSA and
CRA-A (data not shown) complexes.
(C) Solvent accessible surfaces of the active
site regions of the HDAC8:TSA, HDAC8:MS-
344, HDAC8:SAHA, and HDAC8:CRA-A com-
plexes. The MS-344 and SAHA complexes
only possess a catalytic pocket, while the
TSA and CRA-A complexes each possess an
adjacent binding pocket.
tight loop on the protein interior that presents key resi- binding both the nucleophile and the substrate, and (2)
by polarizing the carbonyl of the acetyl-lysine (in concertdues to the active site.
with the hydroxyl of Y306), increasing its electrophilicity.
The charged tetrahedral intermediate resulting from theImplications of the Active Site Structure
nucleophilic attack could be stabilized through interac-for the Catalytic Mechanism
tions with the zinc and interactions with the side chainThe HDAC8 and HDLP structures place constraints on
hydroxyl of Y306. The collapse of the tetrahedral inter-possible catalytic mechanisms employed by the class
mediate would yield the acetic acid and lysine products.I and II HDACs. A likely first step in the deacetylation
Finnin et al. (1999) have suggested that H143 protonatesreaction is a nucleophilic attack on the carbonyl carbon
the lysine after the carbon-nitrogen scissile bondof the substrate. Given that none of the residues in the
breaks. In the HDAC8 structures, the histidine is approxi-vicinity of the substrate are reasonable nucleophiles, it
mately 4 A˚ from where we would expect the amino groupseems probable that this function is carried out by a
of the lysine to end up during catalysis, suggesting thatzinc-bound water molecule (Figure 3D). In the HDAC8
the protonation of the histidine may be water mediated.complex structures presented here, the hydroxyl group
of the hydroxamic acid is likely a structural mimetic of
the catalytic water. The zinc would lower the pKa of a The Structures of the Four HDAC8:Inhibitor
Complexes Show that the Surface of HDAC8water proton, making the water more nucleophilic. The
nucleophilicity of the water would probably also be in- in the Vicinity of the Active Site
Is Extremely Malleablecreased through hydrogen bonds with the N2 of H142
and H143. In addition to affecting the pKa of the water, A comparison of the structures of the four HDAC8:inhibi-
tor complexes presented here reveals considerablethe zinc could facilitate the deacetylation reaction in two
ways: (1) by reducing the entropy of the reaction by structural differences in the protein surface in the vicinity
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of the opening to the active site (Figure 4). These differ-
ences suggest that this region is highly malleable and
is able to change to accommodate binding to a variety
of different ligands. From a physiological point of view,
this flexibility suggests that HDAC8 might be able to
bind to acetylated lysines that are presented in a variety
of structural contexts.
The differences that are observed in the HDAC8 sur-
face around the active site are primarily mediated by
the L1 loop (S30-K36) (Figures 2C, 4A, and 4B). Among
the four complexes, the position of the -carbon of K33
in the L1 loop varies by as much as 6 A˚ with respect to
the protein core. In the HDAC8:CRA-A complex, the
L1 loop peels away from the protein, exposing a deep
binding groove immediately adjacent to the acetyl-lysine
binding site (Figure 4C). This groove measures approxi-
mately 13  5 A˚ and reaches a depth of about 15 A˚.
Figure 5. Relative Positions of the HDAC8 Active Site and the Phos-
F152 and Y306, which line the catalytic pocket, also line phorylation Site on Serine 39
the second pocket. In the HDAC8:TSA complex, the Solvent-accessible surface of the structure of HDAC8:TSA showing
conformation of the protein changes in two ways with the TSA molecule binding in the active site (green), the TSA binding
respect to the HDAC8:CRA-A complex: (1) several of in the second site (cyan), and serine 39 (red).
the residues that line the groove collapse inwards, and
(2) loop L2 (residues 97–103), which is poorly ordered
about HDAC8 flexibility to the other class I HDACs. Se-in the HDAC8:CRA-A structure, becomes ordered due to
quence alignments of HDAC8 with the remaining classa - stacking interaction between the dimethyl aniline
I HDACs suggest that the other enzymes in the familymoiety of the active site bound TSA and Y100. The effect
possess longer L1 loops, structurally similar to the loopof these changes is to close off a large part of the second
observed in HDLP (Figure 1). Based on the apparentbinding groove, leaving a narrower second pocket. Sur-
rigidity of the HDLP active site described above, it isprisingly, this second cavity is filled by a second TSA
reasonable to assume that HDAC1, 2, and 3 also pos-molecule (Figures 3A and 4C), which appears to have
sess more conformationally static active sites thaninduced the collapse of the pocket to optimize protein-
HDAC8. However, a definitive and thorough picture ofligand interactions. The second TSA molecule is rotated
active site flexibility and function of the other HDACsby approximately 150	 with respect to the TSA bound
will require an understanding of how they each react toin the catalytic pocket, and inserts its dimethyl aniline
accommodate different bound ligands, or ligands boundhead group into the second pocket where it interacts
in different environments. The identification of potentwith several hydrophobic residues (Figure 3A). The hy-
and selective HDAC inhibitors will require similar infor-drophobic linker of the second TSA molecule sticks out
mation. Potent inhibitors can be identified by targetingof the second pocket and interacts with the ac-
the well-conserved catalytic machinery and bindingtive site bound TSA (Figures 3A and 4C). In the
pocket. However, the identification of compounds thatHDAC8:MS344 and HDAC8:SAHA structures, the L1
specifically inhibit a single member of the HDAC familyloop moves toward the active site and positions K33 so
will be aided by a clear picture of the structure andthat the side chain methylene groups pack against the
flexibility of the surface of each HDAC.F152 side chain, resulting in the occlusion of the second
pocket (Figure 4). The fact that HDAC8 is capable of
The HDAC8 Structure Suggests How the Protein’sexposing a large second cavity suggests that the en-
Activity Is Regulated by Phosphorylation at Serine 39zyme could deacetylate lysine residues that are sur-
Lee et al. (2004) have shown that serine 39 of HDAC8rounded by bulky amino acids, or in environments where
is phosphorylated in vivo and in vitro by PKA, and thatthe lysine residues are partially buried.
phosphoryation leads to a decrease in the enzyme’sNone of the HDLP structures exhibits an exposed
activity. S39 lies at the surface of HDAC8, roughly 20 A˚second binding site, presumably because HDLP has a
from the opening to the HDAC8 active site and roughlylonger L1 loop than HDAC8 (Figures 1 and 2C). Analysis
13 A˚ from the opening to the second binding site (Figureof the HDLP structure indicates that it also possesses
5). S39 resides in a surface pocket comprising severala deep pocket adjacent to the active site, but that the
hydrophobic residues, including V25, A38, F336, andpocket is occluded by the longer loop. The conformation
part of H42. In addition, the hydroxyl group of the serineof this loop is virtually identical in the three HDLP struc-
is flanked on opposite sides of the pocket by two acidictures (Finnin et al., 1999), suggesting that the surface
residues: E335 and D29. The D29 side chain hydrogenof HDLP is less malleable than that of HDAC8 around
bonds with the serine hydroxyl group. It is also interest-the binding site pocket. The apparent reduced flexibility
ing to note that a lysine residue, K36 has its side chainin the HDLP surface may also explain why it is less
positioned between S39 and the active site pocket, 5 A˚efficient in histone deacetylase assays (Finnin et al.,
from S39. This places K36 within range to directly inter-1999).
act with phosphorylated S39. It is clear from the HDAC8Using the structural comparisons between HDAC8
and HDLP, we can extrapolate the information gained structure that the placement of a phosphate in this envi-
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Figure 6. Schematic View of the Solid-Phase
Synthesis of CRA-A
BRL). Expression using this vector results in a fusion protein withronment would lead to a major structural disruption of
an N-terminal poly-histidine affinity tag. Recombinant baculovirusthis region of the surface.
incorporating the HDAC gene was generated by transposition withThere are two plausible ways in which a disruption of
the Bac-to-Bac system (Invitrogen), and high-titer viral stocks were
the structure in the vicinity of S39 might negatively affect generated by infection of Spodoptera frugiperda Sf9 cells. The ex-
the protein’s activity. One possibility is that the structural pression of recombinant protein was carried out in either Tri-
rearrangement provoked by the phosphorylation ex- choplusia ni Hi5 cells (Invitrogen) or in Sf9 cells.
tends to the HDAC8 active site, thus disrupting activity.
This possibility seems fairly likely given that S39 inter- Purification
The protein used for the TSA, SAHA, and MS344 complexes wasacts with structural elements that extend into the active
isolated from cell extracts by passage over ProBond (Invitrogen)site, including K36, which forms part of the conforma-
resin and concentrated to 10–16 mg/ml. Protein samples weretionally mobile L1 active site loop. Given the flexibility
stored at 4	C in 25 mM Tris-HCl (pH 7.6), 250 mM NaCl, and 0.1 mM
that has been observed for this region of the protein, Tris(2-carboxyethyl)phosphine hydrochloride (TCEP).
S39 phosphorylation may induce a conformation of the To purify the protein used to crystallize the HDAC8:CRA-A com-
L1 loop that precludes catalytically competent substrate plex, infected Sf9 cells were harvested 72 hr post infection and
stored at80	C. Frozen cells were lysed by thawing at room temper-binding. A second possibility is that S39 forms part of
ature in a buffer consisting of 50 mM Tris-HCl (pH 7.9), 200 mMthe surface that interacts with the target histone and
NaCl, 1 mM TCEP, and a protease inhibitor mix (EDTA free) (Rochethat the disruption of the HDAC8-histone interaction in-
Molecular Biochemicals). The lysate was cleared by centrifugation,terferes with activity.
and loaded onto Ni-NTA resin (Qiagen) which had been equilibrated
with 20 mM Tris-HCl (pH 8.0), 30 mM imidazole, 1 M NaCl, and 0.25
Conclusions mM TCEP. Bound protein was eluted with 20 mM Tris-HCl (pH 7.0),
Our results on human HDAC8 provide the first structure 500 mM NaCl, 250 mM imidazole, and 0.25 mM TCEP. The eluted
protein solution was concentrated on YM10 membrane (Millipore)of a member of the class I or class II histone deacety-
and further purified on a Sephacryl S 200 gel filtration column. Thelases. The HDAC8 structure places strong constraints
final elution buffer was 25 mM Tris-HCl (pH 7.6), 150 mM NaCl, andon how catalysis occurs in this family of enzymes, and
0.25 mM TCEP.leads to a proposed catalytic mechanism that is similar
to the mechanism proposed for HDLP. The structures
Synthesis of CRA-Aalso suggest that malleability of the HDAC8 surface
The synthetic procedure used for the preparation of CRA-A is out-
plays an important role in its activity, and provide insight lined in Figure 6. Solid-phase synthesis using commercially available
on how the phosphorylation of serine 39 affects histone hydroxylamine Wang resin proved to be a straightforward method
deacetylation. Finally, these HDAC8 structures provide for the parallel preparation of numerous analogs. A series of amide
coupling reactions followed by the liberation of the hydroxamic acida picture of how inhibitors that are currently in clinical
from the resin afforded materials of the same or better quality thantrials bind to the enzyme, and provide a starting point
those generated via solution phase methods.for the design of novel HDAC inhibitors.
CrystallizationExperimental Procedures
Crystals of the HDAC8:TSA complex were grown in sitting drops by
vapor diffusion. A 50 nl protein drop (10 mg/ml HDAC8, 25 mM Tris-Expression
HCl [pH 7.6], 250 mM NaCl, 0.1 mM TCEP, 2 mM TSA, and 5 mMThe HDAC8 gene was amplified from a cDNA clone by PCR and
cloned into the pSXB2 vector, a derivative of pFastbacHTa (GIBCO- CaCl2) was mixed with 50 nl of reservoir solution (12.15% [v/v] PEG
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8000, 0.2 M calcium acetate, and 100 mM imidazole [pH 6.7]) and References
incubated at 4	C. Crystals typically grew to their final size of 50–100
uM within 48 hr. Crystals used for data collection were soaked in Almenara, J., Rosato, R., and Grant, S. (2002). Synergistic induction
reservoir solution supplemented with 30% glycerol before cryo- of mitochondrial damage and apoptosis in human leukemia cells by
cooling. flavopiridol and the histone deacetylase inhibitor suberoylanilide
To obtain crystals of the HDAC8:MS-344 and HDAC8:SAHA com- hydroxamic acid (SAHA). Leukemia 16, 1331–1343.
plexes, HDAC8 protein (13 mg/ml HDAC8, 25 mM Tris-HCl [pH 7.6], Ayer, D.E. (1999). Histone deacetylases: transcriptional repression
100 mM NaCl, 0.1 mM TCEP, and 5 mM CaCl2) was incubated with with SIN-ers and NuRDs. Trends Cell Biol. 9, 193–198.
2 mM SAHA or MS-344. Crystals were grown from sitting drops,
Bru¨nger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
where 50 nl protein was mixed with an equal volume of reservoir
Grosse-Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, M.,
solution (18% [v/v] PEG 8000 and 100 mM HEPES [pH 7.6]). Crystals
Pannu, N.S., et al. (1998). Crystallography & NMR system: a new
used for data collection were soaked in reservoir solution supple-
software suite for macromolecular structure determination. Acta
mented with 20% glycerol before cryocooling.
Crystallogr. D. 54, 905–921.
The HDAC8:CRA-A complex was crystallized from sitting drops
Buggy, J.J., Sideris, M.L., Mak, P., Lorimer, D.D., McIntosh, B., andconsisting of 2 l of a protein solution (12 mg/ml HDAC8, a 3-fold
Clark, J.M. (2000). Cloning and characterization of a novel humanmolar excess of the CRA-A inhibitor, 0.2 mM ZnCl2, and 1 mM EDTA)
histone deacetylase, HDAC8. Biochem. J. 350, 199–205.and 1 l of the reservoir buffer (0.2 M KCl, 20% [w/v] PEG 3350,
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